107 related articles for article (PubMed ID: 14534856)
1. Anidulafungin Vicuron.
Martin-Mazuelos E
IDrugs; 2003 Oct; 6(10):980-6. PubMed ID: 14534856
[TBL] [Abstract][Full Text] [Related]
2. Anidulafungin: ECB, LY 303366, V-echinocandin, VEC, VER 002, VER-02.
Drugs R D; 2003; 4(3):167-73. PubMed ID: 12757403
[TBL] [Abstract][Full Text] [Related]
3. Emerging echinocandins for treatment of invasive fungal infections.
Turner MS; Drew RH; Perfect JR
Expert Opin Emerg Drugs; 2006 May; 11(2):231-50. PubMed ID: 16634699
[TBL] [Abstract][Full Text] [Related]
4. Anidulafungin: review of a new echinocandin antifungal agent.
Raasch RH
Expert Rev Anti Infect Ther; 2004 Aug; 2(4):499-508. PubMed ID: 15482216
[TBL] [Abstract][Full Text] [Related]
5. Anidulafungin: a novel echinocandin.
Vazquez JA; Sobel JD
Clin Infect Dis; 2006 Jul; 43(2):215-22. PubMed ID: 16779750
[TBL] [Abstract][Full Text] [Related]
6. Anidulafungin: a new echinocandin with a novel profile.
Vazquez JA
Clin Ther; 2005 Jun; 27(6):657-73. PubMed ID: 16117974
[TBL] [Abstract][Full Text] [Related]
7. FK 463.
Drugs R D; 1999 Feb; 1(2):172-3. PubMed ID: 10566017
[No Abstract] [Full Text] [Related]
8. Anidulafungin: a new echinocandin for candidal infections.
de la Torre P; Reboli AC
Expert Rev Anti Infect Ther; 2007 Feb; 5(1):45-52. PubMed ID: 17266452
[TBL] [Abstract][Full Text] [Related]
9. LY 303366. ECB.
Drugs R D; 1999 Feb; 1(2):176-8. PubMed ID: 10566019
[No Abstract] [Full Text] [Related]
10. Anidulafungin (Eli Lilly & Co).
Hawser S
IDrugs; 1999 Dec; 2(12):1327-35. PubMed ID: 16113965
[TBL] [Abstract][Full Text] [Related]
11. The echinocandins.
Cappelletty D; Eiselstein-McKitrick K
Pharmacotherapy; 2007 Mar; 27(3):369-88. PubMed ID: 17316149
[TBL] [Abstract][Full Text] [Related]
12. Echinocandin antifungals: review and update.
Morrison VA
Expert Rev Anti Infect Ther; 2006 Apr; 4(2):325-42. PubMed ID: 16597212
[TBL] [Abstract][Full Text] [Related]
13. Micafungin: a new echinocandin.
Chandrasekar PH; Sobel JD
Clin Infect Dis; 2006 Apr; 42(8):1171-8. PubMed ID: 16575738
[TBL] [Abstract][Full Text] [Related]
14. Photoaffinity analog of the semisynthetic echinocandin LY303366: identification of echinocandin targets in Candida albicans.
Radding JA; Heidler SA; Turner WW
Antimicrob Agents Chemother; 1998 May; 42(5):1187-94. PubMed ID: 9593148
[TBL] [Abstract][Full Text] [Related]
15. Caspofungin. L 743872, MK 0991, MK 991.
Drugs R D; 1999 Feb; 1(2):165-7. PubMed ID: 10566014
[No Abstract] [Full Text] [Related]
16. Anidulafungin pharmacokinetics and microbial response in neutropenic mice with disseminated candidiasis.
Gumbo T; Drusano GL; Liu W; Ma L; Deziel MR; Drusano MF; Louie A
Antimicrob Agents Chemother; 2006 Nov; 50(11):3695-700. PubMed ID: 16954319
[TBL] [Abstract][Full Text] [Related]
17. Progressive loss of echinocandin activity following prolonged use for treatment of Candida albicans oesophagitis.
Laverdière M; Lalonde RG; Baril JG; Sheppard DC; Park S; Perlin DS
J Antimicrob Chemother; 2006 Apr; 57(4):705-8. PubMed ID: 16464893
[TBL] [Abstract][Full Text] [Related]
18. Anidulafungin (Eraxis) for Candida infections.
Med Lett Drugs Ther; 2006 May; 48(1235):43-4. PubMed ID: 16770294
[No Abstract] [Full Text] [Related]
19. The echinocandins, first novel class of antifungals in two decades: will they live up to their promise?
Graybill JR
Int J Clin Pract; 2001 Nov; 55(9):633-8. PubMed ID: 11770362
[TBL] [Abstract][Full Text] [Related]
20. Novel echinocandin antifungals. Part 1: novel side-chain analogs of the natural product FR901379.
Tomishima M; Ohki H; Yamada A; Maki K; Ikeda F
Bioorg Med Chem Lett; 2008 Feb; 18(4):1474-7. PubMed ID: 18207736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
